Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
67.60
+1.20 (1.81%)
At close: Sep 3, 2026
| Market Cap | 7.26B +6.1% |
| Revenue (ttm) | 10.57B +24.8% |
| Net Income | 606.13M +35.3% |
| EPS | 5.60 +34.4% |
| Shares Out | 107.42M |
| PE Ratio | 12.06 |
| Forward PE | n/a |
| Dividend | 1.40 (2.11%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 318,759 |
| Open | 67.00 |
| Previous Close | 66.40 |
| Day's Range | 66.50 - 68.50 |
| 52-Week Range | 45.50 - 78.00 |
| Beta | 0.20 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2026 |